Detalhe da pesquisa
1.
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial.
PLoS One
; 17(10): e0274943, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36256646
2.
Pharmacovigilance capacity strengthening for WHO prequalification: The case of the trivalent influenza vaccine manufactured by Instituto Butantan.
Vaccine
; 37(52): 7560-7565, 2019 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31590933